Results from a US multicenter study presented at CHEST show e-Lung could have sped up Progressive Pulmonary Fibrosis (PPF) diagnosis by up to 21 months. The data marks a significant validation of Brainomix's e-Lung software as a tool to support earlier intervention in lung fibrosis pathways.